☆ 4.7 Letter

Artesunate is Ineffective in Controlling Valganciclovir-Resistant Cytomegalovirus Infection

CLINICAL INFECTIOUS DISEASES (2011)

期刊

CLINICAL INFECTIOUS DISEASES

卷 52, 期 2, 页码 279-279

出版社

OXFORD UNIV PRESS INC

DOI: 10.1093/cid/ciq050

关键词

-

类别

Immunology Infectious Diseases Microbiology

向作者/读者索取更多资源

Protocol

Reagent

作者

我是这篇论文的作者

点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7

评分不足

次要评分

新颖性

-

重要性

-

科学严谨性

-

评价这篇论文

推荐

Article Ophthalmology

Ganciclovir-resistant cytomegalovirus retinitis in a 4-month-old infant

Galia A. Deitz, Emily A. McCourt, Alan Palestine, Ellen R. Miller, Michael J. Bozzella

Summary: We report a case of ganciclovir-resistant cytomegalovirus retinitis in a 4-month-old boy with congenital CMV infection. This case highlights the potential usefulness of intermittent viral load monitoring and retinal examinations in cases of congenital CMV with retinitis.

JOURNAL OF AAPOS (2022)

添加到收藏夹

Review Pharmacology & Pharmacy

Clinical outcome and the role of antivirals in congenital cytomegalovirus infection

Shannon A. Ross, David Kimberlin

Summary: cCMV infection is a major cause of hearing loss and neurological disabilities in children globally. Most infants with cCMV are asymptomatic at birth, but 10-15% will develop hearing loss. Diagnosis relies on detecting the virus from urine or saliva within the first three weeks of life, with saliva PCR being the preferred method. Prevention strategies are limited, and antiviral therapy is standard for infants with symptomatic cCMV.

ANTIVIRAL RESEARCH (2021)

添加到收藏夹

Article Infectious Diseases

Cytomegalovirus in renal transplant recipients from living donors with and without valganciclovir prophylaxis and with immunosuppression based on anti-thymocyte globulin or basiliximab

Jorge Andrade-Sierra, Alejandro Heredia-Pimentel, Enrique Rojas-Campos, Diana Ramirez Flores, Jose Cerrillos-Gutierrez, Alejandra G. Miranda-Diaz, Luis A. Evangelista-Carrillo, Petra Martinez-Martinez, Basilio Jalomo-Martinez, Eduardo Gonzalez-Espinoza, Benjamin Gomez-Navarro, Miguel Medina-Perez, Juan Jose Nieves-Hernandez

Summary: In renal transplant recipients, low doses of ATG may increase the risk of developing CMV, while the use of basiliximab may be more favorable. Additionally, factors such as lack of prophylaxis, ATG use, tacrolimus toxicity, and lymphocyte count at the sixth month post-transplantation are associated with the risk of CMV.

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2021)

添加到收藏夹

Article Infectious Diseases

Correlation of cytomegalovirus viral load between whole blood and plasma of congenital cytomegalovirus infection under valganciclovir treatment

Yuka Torii, Ichiro Morioka, Yasumasa Kakei, Kazumichi Fujioka, Yu Kakimoto, Naoto Takahashi, Tetsushi Yoshikawa, Hiroyuki Moriuchi, Akira Oka, Yoshinori Ito

Summary: This study aimed to compare the accuracy of quantification methods for cytomegalovirus (CMV) infection using whole blood and plasma, and explored the relationship between CMV DNA levels and VGCV therapy. The results showed that plasma CMV viral loads were significantly decreased at the end of therapy, and overall, using plasma to measure CMV viral loads is a feasible approach to monitor the efficacy of CMV infection in children.

BMC INFECTIOUS DISEASES (2023)

添加到收藏夹

Review Microbiology

Renal Involvement in Congenital Cytomegalovirus Infection: A Systematic Review

Maria Rios-Barnes, Claudia Fortuny, Ana Alarcon, Antoni Noguera-Julian

Summary: Although typical pathological features of cCMV infection are commonly seen in renal tissue, they do not seem to have significant consequences at the anatomical or clinical levels.

MICROORGANISMS (2021)

添加到收藏夹

Article Medicine, General & Internal

The Multifaceted Clinical Characteristics of Congenital Cytomegalovirus Infection: From Pregnancy to Long-Term Outcomes

Yejin Kim, Yoo-min Kim, Doo Ri Kim, Han Gyeol Kim, Ji-Hee Sung, Suk-Joo Choi, Soo-young Oh, Yae-Jean Kim, Yun Sil Chang, Dongsub Kim, Jung -Sun Kim, Il Joon Moon, Cheong-Rae Roh

Summary: This study aimed to investigate the clinical characteristics of congenital CMV infection from diagnosis to treatment using a multidisciplinary approach. The results showed that prenatal findings have limited ability to detect congenital CMV in Korea. Developmental delay and hearing loss were common long-term outcomes, emphasizing the need for early antiviral treatment and specific diagnostic strategies to reduce the risks of neurologic impairment.

JOURNAL OF KOREAN MEDICAL SCIENCE (2023)

添加到收藏夹

Article Infectious Diseases

Standard ganciclovir dosing results in slow decline of cytomegalovirus viral loads

Anne-Grete Martson, Marieke G. G. Sturkenboom, Marjolein Knoester, Tjip S. van der Werf, Jan-Willem C. Alffenaar, William Hope

Summary: This study evaluated the pharmacokinetics and pharmacodynamics of ganciclovir in transplant recipients, showing that the dosing of ganciclovir might have been inadequate to achieve a fast reduction of viral load. Further studies are needed to specify the pharmacodynamic effects of ganciclovir.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2022)

添加到收藏夹

Article Transplantation

Cytomegalovirus after kidney transplantation in 2020: moving towards personalized prevention

Rachel Hellemans, Daniel Abramowicz

Summary: CMV-related complications after kidney transplantation present a significant challenge. Tailoring preventive strategies based on individual patient risk levels can improve outcomes. CMV-specific T-cell assays can help predict CMV risk pre-transplantation. Immunosuppressive regimens including mammalian target of rapamycin inhibitors can reduce CMV risk. New antiviral agents and adoptive T-cell therapy hold promise for future treatment options.

NEPHROLOGY DIALYSIS TRANSPLANTATION (2022)

添加到收藏夹

Article Immunology

Valganciclovir Dosing for Cytomegalovirus Prophylaxis in Solid-organ Transplant Recipients on Continuous Veno-venous Hemodialysis

Andrew S. Jarrell, Jessica R. Crow, Sara E. Strout, Rachel M. Kruer, Lindsey P. Toman, Maria Dioverti-Prono, Laura Lees, Robin K. Avery, Mark A. Marzinke

Summary: Valganciclovir 450 mg enterally every 24 hours achieved ganciclovir trough concentrations >= 0.60 mu g/mL in most patients on CVVHD, similar to those reported with intravenous ganciclovir for prophylaxis in this population. Neutropenia did not occur in the study period. Thrombocytopenia was common and likely multifactorial.

CLINICAL INFECTIOUS DISEASES (2021)

添加到收藏夹

Article Infectious Diseases

Cytomegalovirus viremia and advanced HIV disease: is there an argument for anti-CMV treatment?

Caleb P. Skipper, Mark R. Schleiss

Summary: The role of CMV infection in the progression of HIV disease and other opportunistic infections is reviewed in this article. Clinical evidence suggests that CMV viremia is an independent risk factor for the progression of infections caused by C. neoformans and M. tuberculosis. Controlling CMV replication could reduce the risk of opportunistic infections, and the use of CMV antivirals is proposed for this purpose.

EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2023)

添加到收藏夹

Article Multidisciplinary Sciences

Transition from antigenemia to quantitative nucleic acid amplification testing in cytomegalovirus-seropositive kidney transplant recipients receiving preemptive therapy for cytomegalovirus infection

Monica Rika Nakamura, Lucio R. Requiao-Moura, Roberto Mayer Gallo, Camila Botelho, Julia Taddeo, Laila Almeida Viana, Claudia Rosso Felipe, Jose Medina-Pestana, Helio Tedesco-Silva

Summary: The study compares the effectiveness of preemptive treatment for cytomegalovirus (CMV) infection after kidney transplant using antigenemia and RT-PCR testing. It finds that both methods yield similar results in preventing CMV disease and related events. Acute rejection and glomerular filtration rate are identified as risk factors for CMV disease.

SCIENTIFIC REPORTS (2022)

添加到收藏夹

Article Immunology

Cytomegalovirus High-risk Kidney Transplant Recipients Show No Difference in Long-term Outcomes Following Preemptive Versus Prophylactic Management

Kjersti B. Blom, Grete K. Birkeland, Karsten Midtvedt, Trond G. Jenssen, Anna V. Reisaeter, Halvor Rollag, Anders Hartmann, Solbjorg Sagedal, Ivar Sjaastad, Garth Tylden, Gro Njolstad, Einar Nilsen, Andreas Christensen, Anders Asberg, Jon A. Birkeland

Summary: This study compares the long-term outcomes of prophylactic and preemptive CMV preventive strategies in kidney transplant recipients. The study found that there were no significant differences in long-term outcomes such as patient death and graft loss between the two strategies in D+/R- kidney transplant recipients.

TRANSPLANTATION (2023)

添加到收藏夹

Article Infectious Diseases

Detection of antiviral drug resistance in patients with congenital cytomegalovirus infection using long-read sequencing: a retrospective observational study

Yuka Torii, Kazuhiro Horiba, Jun-ichi Kawada, Kazunori Haruta, Makoto Yamaguchi, Takako Suzuki, Hideko Uryu, Naoyuki Kashiwa, Keiji Goishi, Tomoo Ogi, Yoshinori Ito

Summary: This study developed a method for detecting drug resistance mutations in UL97 and UL54 genes using long-read sequencing, and found that antiviral drug resistance can emerge in patients with long-term cCMV therapy.

BMC INFECTIOUS DISEASES (2022)

添加到收藏夹

Article Ophthalmology

Cytomegalovirus-Positive Posner-Schlossman Syndrome: Impact on Corneal Endothelial Cell Loss and Retinal Nerve Fiber Layer Thinning

Matthias Lenglinger, Therese Schick, Dominika Pohlmann, Uwe Pleyer

Summary: This study reports objective morphologic changes in Cytomegalovirus (CMV)-positive Posner-Schlossman syndrome (PSS), showing a correlation between retinal nerve fiber layer (RNFL) thinning, corneal endothelial cell (CEC) loss, and the disease. Elevated intraocular pressures pose a significant challenge. OCT scans and endothelial microscopy may provide guidance for treatment decisions.

AMERICAN JOURNAL OF OPHTHALMOLOGY (2022)

添加到收藏夹

Article Pharmacology & Pharmacy

Delayed graft function and rejection are risk factors for cytomegalovirus breakthrough infection in kidney transplant recipients

Wieteke Kleinherenbrink, Marije Baas, Gizal Nakhsbandi, Dennis A. Hesselink, Joke Roodnat, Brenda C. de Winter, Luuk Hilbrands, Teun van Gelder

Summary: The study found that delayed graft function and rejection significantly increased the risk of CMV disease in renal transplant recipients. Valganciclovir prophylaxis may not provide sufficient protection for CMV IgG-seronegative recipients receiving a kidney from CMV IgG-seropositive donor, especially those with delayed graft function.

PHARMACOLOGICAL RESEARCH (2021)

添加到收藏夹

Article Pediatrics

Post-transplant complications, patient, and graft survival in pediatric and adolescent kidney transplant recipients at a tropical tertiary care center across two immunosuppression eras

Anjali Mohapatra, Anna T. Valson, Vellaichamy M. Annapandian, Vinoi George David, Suceena Alexander, Shibu Jacob, Shailesh Kakde, Santosh Kumar, Antony Devasia, Theophilus S. Vijayakumar, Veerasamy Tamilarasi, Chakko Korula Jacob, Gopal Basu, George Tharayil John, Santosh Varughese

Summary: PAKT in India shows excellent long-term graft outcomes, but patient outcomes are still suboptimal due to a high burden of infections. Current immunosuppression protocols need to be re-examined to balance infection risk, graft, and patient survival.

PEDIATRIC TRANSPLANTATION (2021)

添加到收藏夹

Article Oncology

Combined BRAF, MEK, and CDK4/6 Inhibition Depletes Intratumoral Immune-Potentiating Myeloid Populations in Melanoma

Emily J. Lelliott, Stefano Mangiola, Kelly M. Ramsbottom, Magnus Zethoven, Lydia Lim, Peter K. H. Lau, Amanda J. Oliver, Luciano G. Martelotto, Laura Kirby, Claire Martin, Riyaben P. Patel, Alison Slater, Carleen Cullinane, Anthony T. Papenfuss, Nicole M. Haynes, Grant A. McArthur, Jane Oliaro, Karen E. Sheppard

Summary: Combined inhibition of BRAF, MEK, and CDK4/6 in melanoma patients with BRAF(V600) mutation shows potent tumor control effects but may lead to resistance to immune checkpoint blockade.

CANCER IMMUNOLOGY RESEARCH (2021)

添加到收藏夹

Article Urology & Nephrology

Kidney biopsy practice amongst Australasian nephrologists

J. P. Burke, T. Pham, S. May, S. Okano, S. K. Ratanjee, Z. Thet, J. K. W. Wong, S. Venuthurupalli, D. Ranganathan

Summary: This study surveyed kidney biopsy practices in Australasia and found that they were incongruent with Australian guidelines and lacked consensus on many issues.

BMC NEPHROLOGY (2021)

添加到收藏夹

Article Medicine, General & Internal

Acute Q fever in third trimester pregnancy

Maxwell Braddick, Marion L. Woods, Suji Prabhaharan

Summary: Q fever in pregnancy can lead to obstetric complications, and clarithromycin is an alternative treatment in cases of drug intolerance.

BMJ CASE REPORTS (2021)

添加到收藏夹

Article Oncology

Real-life data for first-line combination immune- checkpoint inhibition and targeted therapy in patients with melanoma brain metastases

Marie-Luise Hilbers, Florentia Dimitriou, Peter Lau, Prachi Bhave, Grant A. McArthur, Lisa Zimmer, Ken Kudura, Camille L. Gerard, Mitchell P. Levesque, Olivier Michielin, Reinhard Dummer, Phil F. Cheng, Joanna Mangana

Summary: The study showed that the combination of immune check-point inhibitors/targeted therapy as the first-line treatment for melanoma brain metastases has certain efficacy, with immunotherapy showing better results in terms of overall survival and outperforming targeted therapy in BRAFV600 patients.

EUROPEAN JOURNAL OF CANCER (2021)

添加到收藏夹

Article Oncology

Melanoma brain metastases that progress on BRAF-MEK inhibitors demonstrate resistance to ipilimumab-nivolumab that is associated with the Innate PD-1 Resistance Signature (IPRES)

Peter Kar Han Lau, Breon Feran, Lorey Smith, Arian Lasocki, Ramyar Molania, Kortnye Smith, Alison Weppler, Christopher Angel, Damien Kee, Prachi Bhave, Belinda Lee, Richard J. Young, Amir Iravani, Hanxian Aw Yeang, Ismael A. Vergara, David Kok, Kate Drummond, Paul Joseph Neeson, Karen E. Sheppard, Tony Papenfuss, Benjamin J. Solomon, Shahneen Sandhu, Grant A. McArthur

Summary: Studies have shown that MBM patients progressing on BRAF-MEKi have lower local response rates to ipilimumab-nivolumab treatment, and MBM patients resistant to BRAF-MEKi also exhibit resistance to second-line ipilimumab-nivolumab. The mechanisms of drug resistance can be identified through whole transcriptome sequencing.

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)

添加到收藏夹

Article Oncology

Enhancing Adoptive Cell Transfer with Combination BRAF-MEK and CDK4/6 Inhibitors in Melanoma

Peter Kar Han Lau, Carleen Cullinane, Susan Jackson, Rachael Walker, Lorey K. Smith, Alison Slater, Laura Kirby, Riyaben P. Patel, Bianca von Scheidt, Clare Y. Slaney, Grant A. McArthur, Karen E. Sheppard

Summary: The combination of adoptive cell transfer (ACT) with BRAF-MEK and CDK4/6 inhibitors has shown to be highly efficacious against BRAF(V600) melanoma, providing prolonged and deep anti-tumor responses. This study offers additional pre-clinical evidence to support the combination of BRAF-MEK-CDK4/6 inhibitors and ACT in clinical trials.

CANCERS (2021)

添加到收藏夹

Article Medicine, General & Internal

Parkinsonism and prolonged cognitive decline as a manifestation of cryptococcal meningitis in a renal transplant patient

Ricky Nelles, Sumudu Britton, George Tharayil John, Charles Denaro

Summary: This case study reports a 67-year-old male recipient of a second renal allograft who presented with progressive cognitive and physical decline, as well as features of Parkinsonism. The patient tested negative for HIV, but his serum and cerebrospinal fluid showed positive results for cryptococcal antigen. Postmortem brain examination revealed a large burden of yeast forms in the substantia nigra, indicating widespread chronic meningitis. This case serves as a reminder of the various neurological presentations that can be associated with cryptococcal infection in solid organ transplant recipients.

BMJ CASE REPORTS (2022)

添加到收藏夹

Article Multidisciplinary Sciences

Adaptive translational reprogramming of metabolism limits the response to targeted therapy in BRAFV600 melanoma

Lorey K. Smith, Tiffany Parmenter, Margarete Kleinschmidt, Eric P. Kusnadi, Jian Kang, Claire A. Martin, Peter Lau, Riyaben Patel, Julie Lorent, David Papadopoli, Anna Trigos, Teresa Ward, Aparna D. Rao, Emily J. Lelliott, Karen E. Sheppard, David Goode, Rodney J. Hicks, Tony Tiganis, Kaylene J. Simpson, Ola Larsson, Benjamin Blythe, Carleen Cullinane, Vihandha O. Wickramasinghe, Richard B. Pearson, Grant A. McArthur

Summary: This study investigates the impact of BRAF inhibition on metabolism in melanoma cells. Through a genome-wide RNA interference screen and gene expression profiling, the researchers found that BRAF inhibition can regulate metabolism through selective mRNA transport and translation. They discovered that U2AF homology motif kinase 1 (UHMK1) associates with mRNAs encoding metabolism proteins and controls their transport and translation during adaptation to BRAF-targeted therapy. Inactivation of UHMK1 leads to cell death and delays resistance to BRAF and MEK combination therapy.

NATURE COMMUNICATIONS (2022)

添加到收藏夹

Article Clinical Neurology

Adult medulloblastoma in an Australian population

Sagun Parakh, Amy Davies, Kerryn Westcott, Daniel Roos, Amal Abou-Hamden, Elizabeth Ahern, Peter K. H. Lau, Sowmya Cheruvu, Ganesalingam Pranavan, Andrew Pullar, James Lynam, Cecelia Gzell, James R. Whittle, Sarah Cain, Po-Ling Inglis, Rosemary Harrup, Antoinette Anazodo, Elizabeth Hovey, Lawrence Cher, Hui K. Gan

Summary: This retrospective study examined the patterns of care and outcomes of adult patients with medulloblastoma in Australia. It found that patients with no residual disease after surgery or with SHH-subtype tumors had higher survival rates. There was substantial variation in the chemotherapy agents used. The study suggests that tailoring treatments based on molecular profiles may improve outcomes for adult medulloblastoma.

JOURNAL OF CLINICAL NEUROSCIENCE (2022)

添加到收藏夹

Review Immunology

Tissue-resident memory T cells in the era of (Neo) adjuvant melanoma management

Kai R. Plunkett, Jesse D. D. Armitage, Andrisha-Jade Inderjeeth, Alison M. M. McDonnell, Jason Waithman, Peter K. H. Lau

Summary: Tissue-resident memory T (T-RM) cells play a crucial role in immune control of melanoma, controlling infections and maintaining dormancy of tumors. They also mediate anti-tumor activity through immune checkpoint inhibitors. These cells are identified by specific markers and high expression of immune checkpoints.

FRONTIERS IN IMMUNOLOGY (2022)

添加到收藏夹

Meeting Abstract Oncology

LOW AND INTERMEDIATE GRADE GLIOMA UMBRELLA STUDY OF MOLECULAR GUIDED THERAPIES (LUMOS) STUDY

Benjamin Kong, Hao-Wen Sim, Benhur Amanuel, Bryan Day, Michael Buckland, Roel Verhaak, Sonia Yip, Terrance Johns, Zarnie Lwin, Mark Rosenthal, Anna K. Nowak, Elizabeth H. Barnes, Andrew M. Scott, Jonathon Parkinson, Rosalind Jeffree, Richard De Abreu Lourenco, Peter Lau, James Whittle, Elizabeth Hovey, Lawrence Cher, Ganessan Kichendasse, Merryn Hall, Cleo Robinson, Marc Thomas, Tindaro Giardina, Emily Tu, Mustafa Khasraw, Eng-Siew Koh, Hui Gan

NEURO-ONCOLOGY (2021)

添加到收藏夹

Meeting Abstract Oncology

THE MULTI-ARM GLIOBLASTOMA AUSTRALASIA (MAGMA) TRIAL

Benjamin Kong, Hao-Wen Sim, Eng-Siew Koh, Hui Gan, Elizabeth H. Barnes, Sonia Yip, Anna K. Nowak, Peter Lau, Katharine Cuff, Eric Khoo, Zarnie Lwin, Adam Cooper, Anthony Dowling, Anthony Linton, Rosemary Harrup, Tracey Dunlop, Elizabeth Hovey, Jonathon Parkinson, Rosalind Jeffree, Merryn Hall, Emily Tu, Diana Andrew, John Simes, Craig Gedye

NEURO-ONCOLOGY (2021)

添加到收藏夹

Review Medicine, General & Internal

Capecitabine for hormone receptor-positive versus hormone receptor-negative breast cancer

Siao-Nge Hoon, Peter K. H. Lau, Alison M. White, Max K. Bulsara, Patricia D. Banks, Andrew D. Redfern

Summary: This review examined the efficacy of capecitabine in hormone receptor-positive and -negative breast cancer patients across different treatment scenarios. Results showed heterogeneity in the effect of capecitabine in the metastatic setting, while improvements were seen in progression-free survival for hormone receptor-positive cancers in the adjuvant setting. Adverse effects such as diarrhea and hand-foot syndrome were noted across all treatment scenarios.

COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2021)

添加到收藏夹

Meeting Abstract Urology & Nephrology

A CASE OF CARDIAC FAILURE, LEFT VENTRICULAR ASSIST DEVICE AND DIALYSIS

S. Chandler, A. Dashwood, S. Ratanjee

NEPHROLOGY (2020)

添加到收藏夹

暂无数据

© Peeref 2019-2024. All rights reserved.